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Epigenetic changes, including histone methylation,
control T cell differentiation and memory formation,
though the enzymes that mediate these processes
are not clear. We show that UTX, a histone H3 lysine
27 (H3K27) demethylase, supports T follicular helper
(Tfh) cell responses that are essential for B cell anti-
body generation and the resolution of chronic viral in-
fections. Mice with a T cell-specific UTX deletion had
fewer Tfh cells, reduced germinal center responses,
lacked virus-specific immunoglobulin G (IgG), and
wereunable to resolvechronic lymphocyticchoriome-
ningitis virus infections. UTX-deficient T cells showed
decreased expression of interleukin-6 receptor-a and
other Tfh cell-related genes that were associated with
increased H3K27 methylation. Additionally, Turner
Syndrome subjects, who are predisposed to chronic
ear infections, had reduced UTX expression in im-
mune cells and decreased circulating CD4+ CXCR5+
T cell frequency. Thus, we identify a critical link be-
tween UTX in T cells and immunity to infection.
INTRODUCTION
Hundreds of millions of people worldwide are infected with
viruses that persist and induce devastating diseases (Virgin
et al., 2009). Viruses such as HIV, HCV, and HBV establish
chronic infections when the adaptive immune response initially
fails to eliminate them. Over time, extended exposure to viral an-
tigens and sustained inflammation further diminishes the T cell
response. In contrast to acute infections, where highly functional
memory T cells form following transient expansion and contrac-
tion phases, chronic infections lead to virus-specific CD8+ T cellexhaustion, in which cells are physically depleted or functionally
inactivated (Wherry, 2011). Overcoming T cell exhaustion in
persistent viral infection is a potential approach to enhance the
antiviral immune response.
CD4+ T cells support CD8+ T cell responses and preferentially
differentiate into the T follicular helper (Tfh) cell subset during
chronic viral infections (Brooks et al., 2005; Fahey et al., 2011;
Matloubian et al., 1994; Thomsen et al., 1996). This increase in
Tfh cell differentiation is enhancedby the repetitive Tcell receptor
(TCR) activation that occurs during persistent infection (Fahey
et al., 2011). As a result, increased populations of virus-specific
Tfh cells are observed during chronic lymphocytic choriomenin-
gitis virus (LCMV) infection of mice, as well as HIV, HBV, and
HCV infections of humans (Fahey et al., 2011; Feng et al., 2012;
Feng et al., 2011; Lindqvist et al., 2012). Tfh cells upregulate
CXCR5, which enables them to relocate to B cell areas of
lymphoid organs. Tfh cells interact with B cells to generate plas-
mablasts or enter germinal centers (GCs) to drive B cell prolifera-
tion, antibody affinitymaturation, isotype class switching, and the
formation of memory B cells and plasma cells (Crotty, 2011). The
shift toward CD4+ Tfh cell differentiation is functionally important
because B cells and antibody production are crucial for eventual
virus control in mouse models of chronic infection (Bergthaler
et al., 2009; Planz et al., 1997). CD4+ Tfh cells also produce inter-
leukin-21 (IL-21), a cytokine that sustains CD8+ T cells during
chronic viral infections (Elsaesser et al., 2009; Fro¨hlich et al.,
2009; Yi et al., 2009). The importance of Tfh cells might be
conserved in humans, as a distinct population of circulating
memory Tfh cells correlates with broadly neutralizing antibodies
against HIV (Locci et al., 2013). Although IL-6 production by follic-
ular dendritic cells is required for Tfh cell responses andcontrol of
chronic LCMV infection (Harker et al., 2011), how virus persis-
tence advances Tfh differentiation is not understood.
The differentiation of CD4+ T helper (Th) cells into distinct
lineages correlates with specific epigenetic modifications (Wei
et al., 2009; Wilson et al., 2009). These epigenetic changes
include post-translational histone methylation, which modulatesImmunity 43, 703–714, October 20, 2015 ª2015 Elsevier Inc. 703
nucleosome structure to regulate transcription factor accessi-
bility. For example, H3K27me3 contributes to repressive chro-
matin and gene silencing, while histone H3 lysine 4 trimethylation
(H3K4me3) is indicative of genes that are actively transcribed
(Bannister and Kouzarides, 2011). The H3K27 methyltransferase
enhancer of zeste homolog2 (EZH2) regulatesTh1andTh2differ-
entiation, andEZH2deficiency enhances interferon-g (IFN-g) and
IL-4 production in vitro, and allergic asthma pathology in vivo
(Tumes et al., 2013). In thesemodels, EZH2-mediated trimethyla-
tion of H3K27 represses gene expression and restricts the differ-
entiation of Th progenitor cells. However, which histone deme-
thylases promote Th lineage differentiation in vivo is not known.
UTX (ubiquitously transcribed tetratricopeptide repeat, X
chromosome; KDM6A), along with UTY and JMJD3 (KDM6B),
are members of an evolutionarily conserved, Jumonji-C (JmjC)
domain-containing family of H3K27me3 demethylases (Agger
et al., 2007).Utx is widely expressed and has functions in biolog-
ical processes ranging from embryonic development to tumor
suppression, and homozygous Utx mutations in the mouse are
embryonic lethal (Shpargel et al., 2012). In this study, we gener-
ated T cell-specific UTX-deficient (UTX-TCD) mice to assess the
in vivo effects of UTX on T cell activation and differentiation
during acute and chronic virus infection. Our results indicate
that UTX is required for optimal CD4+ T cell differentiation to
Tfh cells during chronic, but not acute, virus infection. Moreover,
UTX-TCD mice showed defects in germinal center formation, vi-
rus-specific immunoglobulin G (IgG) production, and clearance
of a chronic viral infection. UTX deficiency resulted in increased
H3K27 methylation and decreased expression at Il6ra and other
Tfh-related genetic loci. Furthermore, human Turner Syndrome
subjects with decreased UTX expression in peripheral blood
also demonstrated decreased numbers of circulating CD4+
CXCR5+ T cells. These results delineate a link between a histone
demethylase in T cells and immunity to chronic virus infection.
RESULTS
Lack of T Cell UTX Does Not Alter Clearance of Acute
Viral Infection
To study the role of UTX in T cells, we generated T cell-specific
UTX-deficient mice by crossing the Utxfl line, which harbors a
floxed third exon, with mice expressing Cre recombinase under
the control of the T cell-specific Lck promoter. Females with a
Cre-mediated Utx deletion in T cells (Utxfl/fl; Lck-Cre), hereafter
referred to as UTX-TCD (T cell deficient), were born at expected
frequencies and matured to adulthood. A T cell-specific
decrease of UTX protein was confirmed by Western blotting of
sorted splenocytes from UTX-TCD mice relative to Utxfl/fl con-
trols (referred to as WT) (Figure S1A). We first evaluated the
role of UTX in T cell thymic development and peripheral mainte-
nance under homeostatic conditions. In 6-week-old UTX-TCD
mice, CD4+ and CD8+ T cell development was unchanged in
the thymus, whilemodest decreases in CD4+ andCD8+ T cell fre-
quencies and numbers were noted in the spleen (Figures S1B
and S1C). Given the modest decrease in peripheral CD4+ and
CD8+ T cells, we assessed the proliferative capacity of UTX-defi-
cient T cells by stimulating CFSE-labeled splenocytes with plate-
bound anti-CD3 and anti-CD28 antibodies. We detected equiv-
alent cell division between WT and UTX-TCD CD4+ and CD8+704 Immunity 43, 703–714, October 20, 2015 ª2015 Elsevier Inc.T cells across a range of anti-CD3 concentrations (Figure S1D).
Thus, the T cell-specific deletion of UTX results in moderate de-
creases in CD4+ and CD8+ T cell numbers without affecting their
proliferative response to in vitro TCR stimulation.
To assess the functional consequence of T cell UTX deficiency
during an in vivo immune response, we infected UTX-TCD mice
with the Armstrong strain of LCMV, which causes an acute infec-
tion that is cleared within a week by CD8+ T cells in WT mice
independently of CD4+ T cells. In UTX-TCD mice, the loss of
UTX had a minimal effect on virus clearance; 6 of 7 UTX-TCD
mice resolved the infection by day 8 and only onemouse showed
a low level of virus at this time (Figure S2A). Tetramer staining re-
vealed that the total numbers of LCMV-specific Db/GP33-41+
CD8+ and I-Ab/GP66-77+ CD4+ T cells 8 days after infection
were unaffected by the absence of UTX (Figure S2B). Further-
more, the total numbers of cytokine producing CD8+ and CD4+
T cells 8 days post infection (pi) were unchanged in the UTX-
TCD mice (Figures S2C and S2D). These data show that virus-
specific UTX-deficient T cells accumulate and function normally
following acute infection. Furthermore, the numbers of cytokine-
producing memory T cells at day 66 pi were not altered in the
UTX-TCD mice (Figures S2E and S2F). Thus, despite reductions
in peripheral T cell numbers under homeostatic conditions (Fig-
ures S1B and S1C), these reductions can be overcome because
UTX-TCDmice generate protective antiviral responses following
an acute viral infection.
T Cell UTX Is Required for Clearance of Chronic Viral
Infection
In contrast to the Armstrong strain, the A22 strain of LCMV es-
tablishes a chronic infection that typically persists for 1–2months
in WT mice (van der Most et al., 1996; Whitmire et al., 2009).
Whereas clearance of the Armstrong strain of LCMV is solely
dependent on CD8+ T cells, the eventual clearance of persistent
LCMV strains, including A22, depends on CD8+ T cells, CD4+
T cells, and B cells (Bergthaler et al., 2009; Matloubian et al.,
1994; Planz et al., 1997). Given the different immune effector re-
quirements for clearing chronic infection, we tested the effects of
T cell-specific UTX deficiency on the control of persistent LCMV-
A22 infection. There was a delay in the clearance of LCMV-A22
from the serumof the UTX-TCDmice (Figure 1A). The initial levels
of virus in the serum were equivalent in the two groups, but the
WT animals subsequently eliminated the infection while the
UTX-TCD mice did not (Figure 1A). The virus levels in the liver,
lung, and kidney were all higher at day 66 pi in the UTX-TCD
mice compared to WT mice (Figure 1B).
Because CD4+ and CD8+ T cells are required to eliminate
chronic LCMV infection, we examined whether UTX deficiency
affects virus-specific CD4+ and/or CD8+ T cell responses. Given
that antiviral T cells are affected by viral loads during the chronic
stage (Fahey et al., 2011; Fuller and Zajac, 2003; Mueller and
Ahmed, 2009; Zajac et al., 1998), we analyzed T cell responses
at day 21 pi, when virus levels were equivalent between the
WT and UTX-TCD mice. At this time point, any alterations in
the T cell responses should be independent of the secondary
effects caused by variations in virus load. We did not detect
any difference in the frequency or number of tetramer-positive
UTX-TCD CD8+ T cells at this time point compared to infected
WT mice (Figure 1C). Furthermore, there was no difference in
Figure 1. T Cell UTX Deficiency Increases the Persistence of a
Disseminating Viral Infection
UTX-TCD and WT littermate control mice were infected with LCMV-A22.
(A) The viral titer in the serum over time.
(B) The level of infectious virus in the indicated tissues at day 66 p.i. The
dashed lines indicate the level of detection.
(C) Examples of Db/GP33-41 staining of gated CD8+CD4CD19- T cells (left)
and the total number of splenic tetramer positive CD8+ T cells at day 21 p.i.
(right).
(D) Examples of PD-1 and Lag-3 staining (left) and their gMFI on gated tetramer
positive CD8+ T cells (right).
(E) Examples of I-Ab/GP66-77 staining of gated CD4+CD8CD19 T cells (left)
and the total number of splenic tetramer positive CD4+ T cells at day 21 p.i.
(right).
All data in this figure are representative of three independent experiments and
shown as means ± SEM. See also Figures S1 and S2.CD8+ T cell expression of the ‘‘exhaustion’’ markers, PD-1 and
Lag-3 (lymphocyte activation gene-3 or CD223) (Figure 1D).
Although CD8+ T cell responses were largely unchanged, UTX-
TCD mice demonstrated a reduced frequency and number of
LCMV-specific antiviral CD4+ T cells at day 21 (Figure 1E). These
data indicate that T cell expression of UTX is critical for the clear-
ance of a chronic virus infection and raise the possibility that UTX
directly regulates CD4+ T cell responses.
CD4+ Tfh Cell Numbers and Function Are Decreased in
UTX-TCD Mice
CD4+ T cells and antibody production by B cells are crucial for
resolving chronic viral infections (Bergthaler et al., 2009; Planzet al., 1997; Richter and Oxenius, 2013). There is an increase
in CD8+ T cell exhaustion and delayed virus clearance when
CD4+ T cells are depleted during chronic LCMV infection (Mat-
loubian et al., 1994). During these chronic infections, CD4+
T cells preferentially differentiate into Tfh cells, which upregulate
CXCR5, migrate into B cell follicles, interact with B cells at
germinal centers (GC), and promote the production of antibodies
(Crotty, 2011). During these T-B interactions within the GCs,
B cells proliferate, mutate their antibody genes, and undergo
immunoglobulin class switching; these events are important in
the production of protective antibody responses. On the basis
of this and the observed overall reduction in CD4+ T cells, we
hypothesized that T cell UTX deficiency might affect CD4+ Tfh
cell numbers and/or function.
We measured Tfh cell generation in WT and UTX-TCD mice at
day 21 pi to determine the effect of UTX on Tfh differentiation dur-
ing chronic virus infection.Notably, apopulation ofCD4+Tcells in
WT animals co-expressed the Tfh markers CXCR5 and PD-1
(programmed cell death protein 1), while the frequency and total
numbers of this population were significantly reduced in UTX-
TCD mice (Figure 2A). The reduced cellularity was specific to
the Tfh pathway because the number of Tbet (TBX21)+ Th1 cells
was not impacted by loss of UTX (Figure 2B). In addition to the
decreased number of Tfh cells, CXCR5+ cells from UTX-TCD
mice showed significant reduction in the expression of multiple
Tfh-related cell surfacemolecules involved in cellular interactions
with B cells, including ICOS, which instructs Tfh development
through upregulation of BCL-6 (Choi et al., 2011); SLAMF6
(Ly108), a receptor that sustains signals into Tfh cells via SAP
(Sh2d1a) and stimulates GC formation (Kageyama et al., 2012);
and PD-1, OX-40 (CD134 or Tnfrsf4), CD84, and CD200 (Figures
2C and S3A–S3D). During chronic virus infection, Tfh cells co-ex-
press IFN-g and IL-21 (Elsaesser et al., 2009), and we found that
the number of IFN-g+IL-21+ Tfh cells was decreased in UTX-TCD
mice (Figure 2D). The total number of CXCR5+ BCL-6+ Tfh cells
was also reduced, without affecting the intensity of BCL-6
staining (Figures S3E and S3F). Thus, UTX-TCD Tfh cells are
reduced in number and show decreased expression of Tfh-
related effector molecules during chronic infection.
Because Tfh cells function to induce B cell antibody produc-
tion in the GCs of lymphoid organs, we next determined the
effects of T cell UTX deficiency on B cell responses. At day
21 pi, we detected significant decreases in the frequency and
total numbers of Fas+GL7+ GC B cells by flow cytometry (Fig-
ure 2E). Moreover, immunohistochemical staining for peanut
agglutinin (PNA)+ GC B cells showed significantly decreased
areas of GCB cells relative to B220+ follicles in UTX-TCD spleens
(Figure 2F). Consistent with the reduction in GCB cells, the levels
of anti-LCMV total-IgG, IgG1, and IgG2c were decreased in
UTX-TCDmice at day 21 pi (Figures 2G and S3G). These findings
suggest that T cell expression of UTX maintains Tfh cell differen-
tiation and subsequent B cell antibody production.
UTX Intrinsically Affects Tfh Cell Numbers during Late
Chronic Virus Infection
Although the data above implicate UTX in Tfh development and
subsequent antibody production during chronic virus infection,
a potential concern is that all T cells in the UTX-TCD mice
lack UTX, including CD8+ T cells, CD4+ T cells, and regulatoryImmunity 43, 703–714, October 20, 2015 ª2015 Elsevier Inc. 705
Figure 2. T Cell Expression of UTX Pro-
motes CD4+ Tfh Development and B Cell
Function during a Chronic Viral Infection
UTX-TCD and WT littermate control mice
were infected with LCMV-A22 and harvested
at d21.
(A) Examples of PD-1 and CXCR5 staining on
gated CD4+CD8CD19 T cells (left) and the total
number of CXCR5+PD-1+ Tfh cells (right).
(B) The total number of T-bet+ CD4+ T cells.
(C) Examples of ICOS and SLAMF6 staining (left)
and their gMFI on gated CD4+CXCR5+CD8
CD19 Tfh cells (right).
(D) The total number of CD4+ T cells producing
IFN-g and IL-21, as measured by ICS.
(E) An example of Fas and GL7 staining on gated
B220+ cells (left) and the total number of GCB cells
(right).
(F) Representative spleen sections stained for
B220 and PNA (top), and the percentage of the
B220+ area that is also PNA+ (bottom).
(G) The serum concentrations of anti-LCMV total
IgG, IgG1, and IgG2c.
(A)–(C) and (E) and (G) are representative of
three independent experiments, (F) is of two in-
dependent experiments, and (D) is of one experi-
ment; all are shown as means + SEM. See also
Figure S3.CD4+ T cell populations. Thus, the effects that we observe for Tfh
cells could be an indirect result of the immunological environ-
ment within the UTX-TCD mice. Alternatively, UTX could have
a cell-intrinsic role in the differentiation of CD4+ T cells into the
Tfh lineage. To distinguish between these two possibilities, we
performed adoptive transfers of virus-specific WT or UTX-TCD
naive CD4+ T cells into wild-type hosts and compared the differ-
entiation of the donor cell populations. UTX-TCD mice were
crossed with LCMV-specific TCR transgenic SMARTAmice (Ox-
enius et al., 1998) that express the congenic Ly5a (CD45.1) allele
to generate UTX-TCD SMARTA mice. Splenocytes from WT
SMARTA mice or UTX-TCD SMARTA mice were adoptively
transferred to wild-type Ly5b+ (CD45.2) C57BL/6 mice, and re-
cipients were infected with the acute Armstrong strain (Figure
S4A) or chronic A22 strain. The WT and UTX-TCD SMARTA cells
were detected in equivalent proportions in uninfected control
mice, indicating that their engraftment and maintenance was
similar in the absence of infection (Figure S4B, left). In response
to acute Armstrong infection, there was no difference in expan-
sion of SMARTA CD4+ T cells or their co-expression of CXCR5
and PD-1 by day 8–9 (Figures S4B–S4D). In response to chronic
A22 virus infection, the WT and UTX-TCD SMARTA cells
expanded similarly (d8–9) and were maintained equivalently at
d22–23 (Figure 3A), indicating that T cell accumulation and sur-
vival are not grossly modulated by UTX. However, by day 22 pi
there was a decrease in the frequency and total number of
CXCR5+PD-1+ UTX-TCD SMARTA Tfh cells (Figures 3B–3D). In
addition to their reduced abundance, the UTX-deficient Tfh cells
expressed lower amounts of the Tfh effector molecule SLAMF6
at days 8 and 22 pi and lower ICOS at day 22 pi (Figure 3E).706 Immunity 43, 703–714, October 20, 2015 ª2015 Elsevier Inc.Whether changes in UTX transcript levels over timemight modu-
late Tfh differentiation was tested in WT SMARTA cells. UTX
mRNA was stable across time during the chronic infection and
also found at similar levels at day 8 of the acute infection (Fig-
ure 3F), indicating that differences in UTXmRNA do not correlate
with Tfh differentiation in these cells. In contrast, BCL-6 expres-
sion levels directly correlated with the frequency of Tfh cells
among the WT SMARTA cells (Figure 3G). Taken together, these
data show that UTX has a cell-intrinsic function in CD4+ T cells
that is crucial for Tfh cell accumulation during an ongoing chronic
virus infection.
Despite similarWT andUTX-TCDSMARTA Tfh cell numbers at
day 8 of the acute and chronic infections (Figures 3D and S4D),
we observed reduced expression of the Tfh effector molecule
SLAMF6 in the absence of UTX (Figure 3E), suggesting that Tfh
function might be altered early during infections. To test this,
we analyzed endogenous Tfh differentiation and function at
day 8 in WT and UTX-TCD mice. We found that Tfh cell numbers
were equivalent at day 8 of acute and chronic infections (Fig-
ure S5A), which was consistent with the SMARTA findings
(Figure 3D). We also observed reduced expression of SLAMF6
on the CXCR5+ cells from the UTX-TCD mice (Figure S5B).
T cell UTX deficiency resulted in reduced B cell responses, as
measured by serum anti-LCMV total IgG, and germinal center
and plasmablast B cell numbers, during acute and chronic infec-
tions (Figures S5C and S5D). These data suggest that even when
found at similar quantities, the UTX-deficient Tfh cells are quali-
tatively affected. Importantly, this functional impairment at early
and late stages of chronic infection is not due to enhanced total
Treg or T follicular regulatory cell (Tfr) subsets (Figure S5E).
Figure 3. UTX Is Required for Tfh Differentiation during Chronic
Virus Infection
WT or UTX-TCD SMARTA CD4+ cells were transferred to C57BL/6 mice fol-
lowed by infection with LCMV-A22 and analyzed at d8–9 and d22–23 after
infection.
(A) The total number of splenic CD4+ Ly5a+ SMARTA cells.
(B) Examples of PD-1 and CXCR5 staining after gating on SMARTA cells.
(C) The frequency of SMARTA cells that are CXCR5+PD-1+.
(D) The total number of SMARTA Tfh cells.
(E) The gMFI of ICOS and SLAMF6 on gated CXCR5+ SMARTA cells.
(F) The relative levels of UTX mRNA in WT SMARTA cells as assessed by qRT-
PCR and normalized to Actb mRNA.
(G) The relative levels of BCL-6 mRNA in WT SMARTA cells as assessed by
qRT-PCR and normalized to Actb mRNA.
All data in this figure are representative of two independent experiments and
shown as means + SEM. See also Figures S4 and S5.UTX Deficiency Alters Tfh Gene Expression via
H3K27me3 Regulation
To understand howUTX alters global gene expression during Tfh
cell specification, we performed RNA-seq expression analysis
of endogenous, polyclonal CD4+CXCR5+CD62Llo Tfh cells that
were FACS-sorted from day 21 A22-infected WT and UTX-
TCD mice. In UTX-TCD compared to WT Tfh cells, we identified54 genes with significantly reduced expression and 34 with
increased expression (Figure 4A and Table S1). Among the
differentially expressed genes in the UTX-TCD Tfh cells, several
Tfh-related genes were downregulated while Th1-related genes
were upregulated (Figure 4B). Expression of Tfh-related genes
such as Icos, Ox-40, Il6ra, and Slamf6 were all significantly
reduced in UTX-TCD Tfh cells. The decreased mRNA for these
genes is consistent with decreased protein levels (Figures 2C
and S3). In contrast, Th1-associated genes such as Eomes,
Ccl4, Ccl5, and Ccr2 were significantly enhanced in UTX-TCD
Tfh cells (Figure 4B). Th1 enhancement has been reported to
occur concurrently with loss of Tfh signaling during viral infection
(Ray et al., 2014). These findings suggest that UTX enforces a
pattern of Tfh gene expression with repression of Th1 genes.
Additionally, other genes, such as Ahnak, Tnfrsf25, and Thy1,
that are associated with T cell homeostasis, activation, or prolif-
eration were also affected by the absence of UTX (Haeryfar and
Hoskin, 2004; Matza and Flavell, 2009; Schreiber and Podack,
2013).
Prevalent UTX-dependent gene activation occurs via
H3K27me3 demethylation. To determine whether the altered
gene expression in UTX-TCD cells is due to the loss of UTX-
mediated histone demethylation, H3K27me3 ChIP-seq was
performed on endogenous, polyclonal Tfh cells (CD4+CXCR5+
CD62Llo) sorted at day 21 pi. EdgeR statistical analysis identified
all promoter regions (transcription start site ± 1KB) that experi-
enced significantly elevated H3K27me3 in UTX-TCD cells. To
facilitate a broad genomic comparison of UTX affected genes,
we measured H3K27me3 accumulation at the promoters of all
genes that experienced significantly downregulated expression
in UTX-TCD Tfh (Table S1). A subset of genes with reduced
expression also demonstrated significant accumulation of pro-
moter H3K27me3 (6 of 54 genes:Cd9, Evl, Il6ra, S1pr1, Tnfrsf25,
and Thy1). The UCSC genome browser H3K27me3 ChIP-seq
tracks for these genes are depicted in Figure 5A. All of the genes
identified in Figure 5A by ChIP-Seq showed increased amounts
of H3K27 in UTX-TCD cells when analyzed by ChIP-qPCR (Fig-
ure 5B). In contrast, several genes with promoters containing
H3K27me3 (Gata3, Hoxb1, Eomes) in WT Tfh cells did not
show increases in H3K27me3 accumulation in UTX-TCD Tfh
cells (Figure 5B and data not shown). The boxplot of log fold
change (FC) for H3K27me3 demonstrates that the overall distri-
bution of genes that were downregulated in UTX-TCD, as
revealed by RNA-seq, is significantly increased in H3K27me3
relative to the genes that were upregulated in UTX-TCD cells
(p value = 0.021, Figure 5C). H3K27me3 ChIP-qPCR confirmed
that there was an enriched distribution of H3K27me3 in UTX-
TCD downregulated genes (p-value = 0.008, Figure 5D). Further-
more, UTX ChIP-qPCR demonstrated enriched UTX occupancy
at the promoters of two targets of UTX H3K27 demethylation
(Il6ra and Thy1; Figure S6A). Therefore, the genes with elevated
H3K27me3 levels in UTX-TCD Tfh are likely to be gene-specific
UTX dependent targets.
During murine chronic virus infection with LCMV-Clone13,
irradiation resistant cells produce IL-6 in a biphasic manner,
with the second IL-6 peak playing a critical role in virus control
(Harker et al., 2011). Consistent with that report, LCMV-A22
infection induced biphasic IL-6 production with a second
peak around day 20 during infection. (Figure S6B). The secondImmunity 43, 703–714, October 20, 2015 ª2015 Elsevier Inc. 707
Figure 4. Tfh Gene Expression Is Altered in
UTX-TCD Mice
CD4+CXCR5+CD62Llo T cells were FACS sorted
from d21 LCMV-A22 infected spleens. RNA was
prepared from 106 cells and subjected to RNA-
sequencing.
(A) An EdgeR analysis of RNA-seq data is pre-
sented as log fold change (logFC) of UTX-TCD
relative to WT plotted against log counts per
million reads (logCPM). Significant (FDR < 0.05)
differences are illustrated as purple circles. Arrows
indicate key genes mis-regulated in UTX-TCD
cells.
(B) The heat map shows individual replicates of
WT and UTX-TCD RNA-seq expression of Tfh or
Th1 signature genes. Darker red denotes higher
expression. Tfh gene expression is reduced in
UTX-TCD cells while Th1 gene expression is
increased.IL-6 peak acts upon IL-6R on CD4+ T cells to drive Tfh
differentiation (Harker et al., 2011; Petrovas et al., 2012). Due
to its function in Tfh differentiation during the late phase of
chronic viral infection, Il6ra stood out among genes identified
with H3K27me3 promoter accumulation at day 21 p.i. with
LCMV-A22. ChIP-qPCR validated a 3.6-fold accumulation of
H3K27me3 at the Il6ra promoter in UTX-TCD Tfh relative to
WT at day 21 p.i. (Figure 5B). The dynamics of Il6ra demethyla-
tion and expression were assessed across a time-course using
cells from uninfected mice (naive; CD62Lhi) and from day 8
(CD62Llo) and day 21 (CXCR5+CD62Llo) after LCMV-A22 infec-
tion. Il6ra was devoid of H3K27me3, and high levels of IL-6Ra
protein were expressed on naive cells from both WT and
UTX-TCD mice (Figures 5E–5G). Early in LCMV-A22 infection
(d8), Il6ra accumulated H3K27me3 and there were reduced
amounts of IL-6Ra protein in both WT and UTX-TCD cells.
However in the later phase of chronic infection (d21), WT Tfh
cells had elevated IL-6Ra expression while UTX-TCD Tfh cells
had enhanced Il6ra H3K27me3 accumulation and reduced IL-
6Ra protein. To determine the functional significance of the
reduced IL-6 receptor expression on UTX-TCD cells, we
compared the responsiveness of UTX-TCD and WT T cells to
IL-6 in vitro. IL-6-induced phosphorylation of STAT3 was un-
changed between WT and UTX-TCD naive CD4+ T cells from
uninfected mice and effector cells from day 8 LCMV-A22
infected mice (Figures S6C and S6D). However at day 21, the708 Immunity 43, 703–714, October 20, 2015 ª2015 Elsevier Inc.phosphorylation of STAT3 was reduced
in UTX-TCD compared to WT T cells
following in vitro culture with IL-6 (Fig-
ure 5H). In contrast, IL-21 stimulated
equivalent phospho-STAT3 levels in WT
and UTX-TCD cells, indicating that the
defect seen in response to IL-6 is not
due to an inherent defect in STAT3
(Figure 5H). These results suggest that
UTX-mediated H3K27me3 demethyla-
tion is a dynamic process that occurs
during the course of a chronic virus
infection to enforce appropriate IL-6Raexpression and downstream function, which includes the pro-
motion of Tfh differentiation.
UTX Expression Is Gene-Dosage Dependent and
Decreased in Turner Syndrome
Utx escapes X-inactivation in both humans and mice (Greenfield
et al., 1998). Thus, UTX is expressed by both X chromosomes in
females. Whether UTX function in T cells is dosage dependent,
however, is not known. We investigated the effects of UTX
dosage on the control of chronic virus infection in mice heterozy-
gous for Utx mutation (Utx+/flLck-Cre; UTX-THet). Cohorts of
UTX-WT, UTX-THet, and UTX-TCD were given LCMV-A22, and
viral loads and T cell responses were followed over time. The
clearance of LCMV-A22 from the serum was delayed in UTX-
THet mice compared to WT mice, but the phenotype was not
as severe as in UTX-TCD mice (Figure 6A). Likewise, the UTX-
THet mice showed intermediate titers of infectious virus in
several tissues at day 55 pi (Figure 6B). The UTX-TCD mice
show reduced Tfh differentiation (Figures 2 and 3), which likely
contributed to the delay in resolving LCMV-A22. Similarly, the
UTX-THet mice had fewer Tfh cells at day 20 (Figures 6C and
6D). These data indicate that a quantitative reduction in UTX
expression diminishes the formation or maintenance of Tfh cells
and impairs immune protection against a chronic virus infection.
UTX gene-dosage dependency is potentially of clinical rele-
vance in humans. Turner Syndrome (TS) occurs in females
Figure 5. A Subset of Genes that Are Misexpressed in UTX-TCD Tfh Cells Show Increased H3K27me3, Including Il6ra
(A–D) CD4+CXCR5+CD62Llo T cells were FACS sorted from d21 LCMV-A22 infected spleens and subjected to H3K27me3 ChIP-seq or ChIP-qPCR.
(A) UCSC genome browser images of H3K27me3 ChIP-seq tracks from d21 LCMV-A22 infected Tfh at selected promoters demonstrating significant H3K27me3
accumulation in UTX-TCD relative to WT.
(B) H3K27me3 ChIP-qPCR verification of d21 LCMV-A22 CD4+CXCR5+CD62Llo T cells. ChIP was performed with an IgG control (gray) or H3K27me3 ChIP in WT
(black) or UTX-TCD cells (white) at indicated genic promoters graphed relative to % input. Npm1 is a negative control locus (active gene) and Gata3 is a positive
control (H3K27me3 repressed).
(C) EdgeR analysis of promoter region (transcription start site ± 1KB) H3K27me3 is presented as logFC of UTX-TCD relative to WT for all genes that were either
downregulated in expression in UTX-TCD (left column) or upregulated (right column) based on RNA-seq. The logFC is normalized relative to the genome average.
All genes experiencing significant H3K27me3 enrichment in UTX-TCD Tfh are labeled as red dots.
(D) H3K27me3 ChIP-qPCR data was quantified as logFC of UTX-TCD relative toWT for select genes that were either downregulated in UTX-TCD or upregulated /
unaltered based on RNA-seq analysis. All genes experiencing significant H3K27me3 enrichment in UTX-TCD Tfh are labeled as red dots.
(E and F) CD4+ T cells were FACS sorted from d0 (naive; CD62Lhi), day 8 of LCMV-A22 (CD62Llo), and day 21 of LCMV-A22 (CXCR5+CD62Llo).
(E) Examples of IL-6Ra staining on WT and UTX-TCD cells at the indicated days.
(F) The gMFI of IL-6Ra on WT and UTX-TCD T cells.
(G) Enrichment of Il6ra promoter proximal H3K27me3 by ChIP-qPCR of WT and UTX-TCD cells. Data is graphed as fold H3K27me3 enrichment at Il6ra over a
control locus lacking H3K27me3 (Npm1).
(H)WT or UTX-TCDSMARTA cells were transferred toWTmice and infectedwith LCMV-A22 as in Figure 3. Splenocytes were harvested on day 22 pi and cultured
with the indicated cytokines for 30 min. The percentage of p-STAT3 positive SMARTA cells after the in vitro culture.
All data in this figure are representative of at least two independent experiments and shown as means + SEM. See also Figure S6.lacking part or all of an X chromosome and is the most common
sex chromosomal abnormality that affects girls and women. TS
is characterized by an array of clinical conditions, includingrecurrent ear infections and alterations in T cell and immunoglob-
ulin subsets, though the mechanisms underlying these immune
changes are not currently known (Cacciari et al., 1981; JensenImmunity 43, 703–714, October 20, 2015 ª2015 Elsevier Inc. 709
Figure 6. Heterozygous T Cell UTX Affects Virus Clearance and Tfh
Differentiation
WT, UTX-THet, and UTX-TCD mice were infected with LCMV-A22.
(A) The serum viral titer was measured over time.
(B) The level of infectious virus in the indicated tissues at day 55 pi. The dashed
lines indicate the level of detection.
(C) Spleens were harvested fromWT andUTX-THetmice on day 21 p.i. and the
cells were analyzed by flow cytometry. Examples of PD-1 and CXCR5 staining
on gated CD4+CD8CD19 T cells.
(D) The total number of Tfh Smarta cells (CXCR5+PD-1+).
All data in this figure are representative of two independent experiments and
shown as means ± SEM.et al., 1976; Mock et al., 2000; Stenberg et al., 1998; Su et al.,
2009). Because TS subjects lack at least part of the second
sex chromosome, decreased expression of X-linked gene(s)
that escape X-inactivation may underlie these immune alter-
ations (Carrel and Willard, 2005). Importantly, UTX is located
on the X chromosome and escapes X-inactivation in both mice
and humans (Greenfield et al., 1998). Given that UTX is subject
to gene-dosage effects, we reasoned thatUTXmight be haploin-
sufficient in TS immune cells.
We utilized global gene-expression profiling using the Agilent
SurePrint G3 Human Gene Expression 8x60K Microarray to
identify candidate genes with altered expression in TS immune
cells. Comparison of peripheral blood mononuclear cells
(PBMCs) from control females to TS subjects with confirmed
45X karyotype showed differential expression of 1169 unique
genes, including 35 that are located on the X chromosome.
UTX was among the 10 genes with the largest decrease in
expression in TS subjects (Figure 7A) and the only gene among
these candidates known to escape X-inactivation (Greenfield
et al., 1998). The decrease inUTX transcript expression was veri-
fied by RT-PCR on cDNA from TS and female control PBMCs
(Figure 7B). These findings suggest a potential causative role
for UTX deficiency in TS immune dysfunction.
We sought to determinewhether decreasedUTX expression in
TS might be associated with decreases in Tfh cells, as we have
observed in mice. As expected, the majority of TS individuals
had a history of recurrent otitis media (Figure S7A). We first
measured the frequency of total, naive (CD45RA+), and anti-
gen-experienced (CD45RO+) CD4+ T cells and found no signifi-
cant differences between controls and TS individuals (Figures
7C–7E). Circulating CD4+CXCR5+ have been correlated with710 Immunity 43, 703–714, October 20, 2015 ª2015 Elsevier Inc.antibody production in humans, thus representing an accessible,
surrogate Tfh-like population (Morita et al., 2011; Pallikkuth et al.,
2012; Simpson et al., 2010). We therefore compared the fre-
quency of circulating CD4+ CXCR5+ T cells in non-TS females
versus TS subjects. There was a 2-fold reduction in the fre-
quency of circulating CD4+CXCR5+ cells from TS subjects (Fig-
ures 7F and 7G). The expression of IL-6R on CXCR5+ CD4+
T cells was modestly decreased in TS subjects, although this
difference did not reach statistical significance because of
an outlier in the control group (Figure S7B). Additionally, the
CXCR5+ cells from TS subjects showed a trend toward dimin-
ished responsiveness to IL-6-induced phosphorylation of
STAT3 compared to cells from controls (Figure S7C). Together,
these findings suggest that UTX deficiency might contribute to
the infection predisposition observed in TS by reducing the fre-
quency of the CD4+ CXCR5+ subset.
DISCUSSION
T cell subset differentiation is highly regulated to ensure that the
adaptive immune system can vigorously fight off diverse patho-
gens while avoiding immune-mediated pathology. Th subtypes
are characterized by distinct H3K27me3 epigenetic profiles
that reflect subtype-specific transcriptional programs (Wei
et al., 2009). These lineage-specific epigenetic changes suggest
that histone-modifying enzymes are crucial in their differentia-
tion. In this study, we identify the H3K27me3 demethylase UTX
as a key regulator of CD4+ T cell differentiation to the Tfh subset
during a chronic virus infection. In the absence of UTX we
observe decreased numbers of Tfh cells, altered germinal cen-
ters, reduced humoral immune responses, and enhanced virus
persistence.
Tfh cells are crucial in vaccine responses and protection from
infection via their ability to promote B cell antibody production
and affinity maturation. Recent data in mice and humans have
demonstrated that chronic virus infections result in enhanced
Tfh differentiation (Fahey et al., 2011; Feng et al., 2012; Feng
et al., 2011; Lindqvist et al., 2012). Interestingly, the development
of Tfh cells appears to be differentially regulated in response to
acute versus chronic virus infections. IL-6 and its cognate recep-
tor (IL-6Ra) are required for Tfh differentiation during chronic
LCMV infection of mice and are strongly correlated with Tfh re-
sponses following SIV infection of macaques (Harker et al.,
2011; Petrovas et al., 2012). Our data indicate that UTX-TCD
Tfh cell frequency was unchanged during acute infection and
early during chronic infection (Figures 3, S4, and S5). However,
the accumulation of UTX-TCD Tfh cells was reduced later during
the chronic infection. Additionally, our data indicate that the
responsiveness of CD4+ T cells toward IL-6 is regulated by
UTX-mediated H3K27me3 demethylation of the Il6ra promoter
during later stages of chronic infection. Together, these findings
suggest that epigenetic regulation of Il6ra by UTX might underlie
the differences seen in acute versus chronic infection.
In addition to the effects of UTX on the number of Tfh cells at
later times during chronic virus infection, UTX also appears to
regulate the function of Tfh cells throughout acute and chronic
infection. At day 8 p.i., the number of Tfh cells was equivalent,
yet the B cell response was decreased in UTX-TCD in compari-
son with WTmice. One possibility is that T cell recruitment into B
Figure 7. UTX Expression Is Decreased in
TS Peripheral Blood Mononuclear Cells
(A) Heat map displaying the relative expression
levels of the 10 X-linked genes that are most
depressed in Turner Syndrome (TS) subject
peripheral blood mononuclear cells (PBMCs).
Expression levels are Z score normalized across
rows.
(B) A comparison of array-based UTX expression
levels across the subjects. UTX expression was
normalized to HPRT in control females and TS
subjects by quantitative RT-PCR.
(C) The frequency of CD4+ T cells among all
PBMCs. The horizontal bar indicates the mean.
(D) The frequency of CD45RA+ cells among gated
CD4+ T cells in the blood. The horizontal bar in-
dicates the mean.
(E) The frequency of CD45RO+ cells among gated
CD4+ T cells in the blood. The horizontal bar in-
dicates the mean.
(F) Examples of PBMCs from control of TS sub-
jects that were co-stained for CD4 and CXCR5.
The ovals identify the CD4+CXCR5+ cells; the
numbers indicate their frequency among all
PBMCs.
(G) The percentage of CD4+CXCR5+ T cells among
all PBMCs. The data is shown as mean + SEM;
n = 5 for healthy controls, n = 7 for TS subjects.
See also Figure S7.cell follicles is defective in the absence of UTX. Another possibil-
ity is that T-B interactions, which are dependent upon the
adaptor protein SAP, are disrupted in the absence of T cell
UTX. We noted a consistent reduction in expression of SLAMF6,
which promotes T-B interactions and recruits SAP, across all
time points in UTX deficient T cells. Therefore, UTX mediated
regulation of SLAMF6 might be involved in promoting Tfh cell
functionality. Further experiments are needed to determine at
what step T cell help for B cells is defective, as well as to test
whether SLAMF6 or other specific targets of UTX regulate this
pathway.
Interestingly, IL-6 expression during chronic LCMV infection
is biphasic, with an early induction followed by silencing and
then a second wave of expression a few weeks later (Harker
et al., 2011). Given that UTX-TCD Tfh cell frequency was un-
changed during the early stage of chronic infection (Figure 3
and S5), we propose that early robust inflammatory signals,
potentially including IL-6, are sufficient to induce Tfh cell devel-
opment in the absence of UTX, as T cell expression of IL-6Ra is
UTX-independent in naive cells and at day 8 (Figure 5). How-
ever, in the context of sustained infection, UTX-mediated de-
methylase activity is required to ensure that virus-specific Tfh
cells are receptive to the second wave of IL-6 expression.
Compared to antibody responses to acute infections or vac-
cines, neutralizing antibody to chronic virus infections often
emerge following a lengthy delay and are thought to requireImmunity 43, 703–714,extensive somatic hypermutation of
immunoglobulin in GCs. Thus, it is plau-
sible that T cell UTX plays a central role
in the formation of neutralizing antibody
during this delayed phase.Global transcriptome analysis identified multiple genes with
reduced expression in UTX-TCD cells, and a small number of
those genes (e.g., Il6ra) had enhanced H3K27me3, indicating
that UTX demethylase activity contributes to their expression.
It was surprising that such a small number of genes showed
enhanced H3K27me3 and reduced expression in the absence
of UTX. One explanation for this might be a potential overlap in
targets between UTX and JMJD3, the other H3K27me3 deme-
thylase expressed in T cells. In addition to the genes dependent
on UTX-mediated demethylation, the expression of several other
Tfh lineage genes in UTX-TCD cells were reduced in the absence
of H3K27me3 accumulation (e.g., Slamf6, Figure 5B). There are
two possible explanations for these UTX-dependent changes
in gene expression. It could be that these genes are not direct
targets of UTX regulation but are induced by factors, such as
activated STAT3, that are downstream of IL-6 signaling that is
potentiated by UTX. Alternatively, it could be that these genes
are induced by UTX in a demethylase-independent manner,
which has been observed in a number of developmental settings.
For example, UTX, aswell as JMJD3, was able to drive IFN-g and
other cytokine production in an EL4 lymphoma line through inter-
actions with T-box transcription factors and nucleosome remod-
eling factors (Miller et al., 2010). UTX may act in a similar fashion
during Tfh differentiation by interacting with and promoting the
activity of Tfh-specific transcription factors independently of its
H3K27me3 demethylase ability.October 20, 2015 ª2015 Elsevier Inc. 711
Finally, our study of TS subjects suggests a potential role for
UTX in human T cells. Recurrent ear infections in TS are well-
recognized, but the underlying mechanism for this is not known
(Stenberg et al., 1998). A study seeking to associate recurrent
ear infections in TS with immune abnormalities did not findmajor
immunological deficiencies in TS patients (Stenberg et al., 2004).
However, other investigations have demonstrated abnormalities
in the T cell compartment and the generation of immunoglobu-
lins, suggesting that recurrent ear infections might reflect a
defect in immune function (Cacciari et al., 1981; Jensen et al.,
1976; Mock et al., 2000). In line with the latter studies, our anal-
ysis demonstrates that TS immune cells are UTX deficient and
the frequency of circulating CD4+ CXCR5+ T cells is reduced
in TS. A caveat to this result, however, is that circulating CD4+
CXCR5+ T cells likely represent a heterogeneous population
(He et al., 2013; Locci et al., 2013). Interestingly, UTX muta-
tions have recently been described in Kabuki Syndrome, a rare
congenital disorder in which susceptibility to infections has
also been described (Lederer et al., 2012). Remarkably, recur-
rent ear infections also occur in 63% of Kabuki Syndrome pa-
tients (Matsumoto and Niikawa, 2003). Thus, two independent
syndromes associated with a loss of UTX function share
increased susceptibility to chronic ear infection. Our findings
describing the role of UTX in CD4+ T cells provide a mechanism
for the immune dysfunctions in these two syndromes.
EXPERIMENTAL PROCEDURES
See Supplemental Experimental Procedures for details.
Mice
All mouse experimental procedures were approved by the University of North
Carolina Institutional Animal Care and Use Committee. Utxfl/fl mice were back-
crossed to C57BL/6J for > 5 generations. These mice were then crossed to
Lck-Cre (Hennet et al., 1995) and Ly5a+ (CD45.1) SMARTA TCR-transgenic
lines that have CD4+ T cells specific for the LCMV epitope GP61–80 presented
by I-Ab (Oxenius et al., 1998). All mouse experimental procedures were
approved by the University of North Carolina Institutional Animal Care and
Use Committee.
Virus
Mice were infected by intraperitoneal injection of 2 3 105 PFU of LCMV-Arm-
strong or intravenous injection of 2 3 106 PFU LCMV-A22. LCMV was pre-
pared from BHK cells and quantified by plaque assay on Vero cell monolayers.
RNA-Seq
RNA was extracted from FACS-sorted CD4+CXCR5+CD62Llo T cells (106 cells
total) from day 21 pi and purified on oligo(dT) dynabeads for cDNA amplifica-
tion. Adaptors were ligated and 100 bp reads were sequenced by the HiSeq
2000 Analyzer located at the Scripps DNA Sequencing Facility. Data were
deposited in GEO database under accession number GSE64969.
Human Samples
Allhuman researchwasapprovedby theUniversity ofNorthCarolina Institutional
ReviewBoard, andwritten informed consent was obtained from all participants.
PBMCRNA from ten Turner Syndromesubjects andfive control female subjects
were labeledandhybridized to theAgilentSurePrintG3HumanGeneExpression
8 3 60K Microarray. In the case where microarray chips were scanned on
different dates, batch effect was identified and removed (Partek Genomics
SuiteTM). See Supplemental Experimental Procedures for analysis details.
Adoptive Transfers
Spleen cells were isolated from WT or UTX-TKO Ly5a+ SMARTA TCR
transgenic mice. The frequency of CD4+ T cells was determined by flow cy-712 Immunity 43, 703–714, October 20, 2015 ª2015 Elsevier Inc.tometry, and the spleen cells were adjusted so that 5 3 103 Smarta CD4+
T cells were injected intoWT C57BL/6 mice (Ly5b+Ly5a) via tail vein injection.
The cells were allowed to engraft for 4 days before the recipient mice were
infected.
Antibody Levels
Sera were collected and virus-specific IgG was measured by ELISA using
plates coated with virus-infected or uninfected BHK lysates (Whitmire et al.,
1996). The highest dilution at which the OD value reached 1.5 (roughly 50%
maximal response) was calculated for each sample.
Immunohistochemistry
Formalin-fixed paraffin-embedded spleen sections were stained with fluores-
cent antibodies or peanut-agglutinin and imaged on a Zeiss-710 confocal laser
scanning microscope at the UNC Microscopy Services Laboratory.
Phospho-STAT3 Staining
Mouse splenocytes or human PBMCs were cultured with recombinant
mouse or human IL-6, respectively (both from Peprotech). The cells were
then surface stained, fixed, permeabilized with Perm Buffer III (BD Biosci-
ences) and stained with mouse anti-human STAT3 (pS727) Clone 49/p-
STAT3 (BD Biosciences).
ChIP
FACS-sorted CD4+CXCR5+CD62Llo T cells (2 3 106 cells per replicate) from
day 21 p.i. were crosslinked with 0.6% formaldehyde and sonicated (Bioruptor
Sonifier). ChIP was performed with anti-H3K27me3 (Abcam ab6002, 2 mg)
(Rahl et al., 2010). UTX ChIP was performed on in vitro differentiated Tfh (Lu
et al., 2011) and 13 107 nuclei were subjected to micrococcal nuclease diges-
tion (2,000 U/ml for 15 min at 37 degrees) prior to ChIP with UTX antibody (Ag-
ger et al., 2007). Data from ChIP-seq were deposited in GEO database under
accession number GSE64969.
Statistics
All bar graphs are presented as mean + SEM. Significance was determined by
unpaired Students t test. * p < 0.05, ** p < 0.01, and *** p < 0.001.
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The GEO accession number for the data reported in this paper is GSE64969.
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